A detailed history of Marshall Wace, LLP transactions in Privia Health Group, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 159,711 shares of PRVA stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,711
Holding current value
$3.17 Million
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.95 - $21.29 $2.71 Million - $3.4 Million
159,711 New
159,711 $2.91 Million
Q3 2022

Nov 14, 2022

SELL
$28.9 - $42.97 $152,736 - $227,096
-5,285 Reduced 15.23%
29,425 $1 Million
Q2 2022

Aug 15, 2022

SELL
$18.74 - $29.78 $7.81 Million - $12.4 Million
-416,871 Reduced 92.31%
34,710 $1.01 Million
Q1 2022

May 16, 2022

BUY
$19.16 - $27.29 $4.16 Million - $5.93 Million
217,237 Added 92.7%
451,581 $12.1 Million
Q4 2021

Feb 14, 2022

BUY
$21.14 - $32.49 $4.95 Million - $7.61 Million
234,344 New
234,344 $6.06 Million

Others Institutions Holding PRVA

About Privia Health Group, Inc.


  • Ticker PRVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 111,326,000
  • Market Cap $2.21B
  • Description
  • Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population...
More about PRVA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.